REVIVER is a unique medical rehabilitation device designed to exercise, tone and condition the body in order to PREVENT, REDUCE or SLOW the progress of disability and disease. The controlled radial wavelike motions against gravity are designed to stimulate reflexive muscle reactions and gravitational epigenetic responses in different organs and tissues to stimulate a healing/rehabilitation response.
REVIVER's near EFFORTLESS EXERCISE therapy has application for treating neurological disorders including Parkinson's disease, Multiple Sclerosis, Cerebral Palsy, Autism and Stroke.
The Isodynamic REVIVER device and program demonstrates significant health benefits that have not previously been readily available, including: - Muscle-strengthening in impaired participants who would otherwise have difficulty in exercising. - Recruiting reflex actions that stimulate areas of the body that may have become dormant. - Acting in contrast to other types of assisted exercise by training the body's entire muscular system in a single motion.
- Providing neural (nervous) stimulation via the periodic displacement of vestibular fluids of the balancing system, possibly stimulating neuroplasticity beyond that provided by existing exercise therapies.
- Creating strength, balance, mobility and well-being in a single user-friendly motion.
*No other device is known to have all these attributes in a single machine or system
Over the past three years at Isodynamic REVIVER Clinic in Sydney Australia, exceptional outcomes have been reported by clients with a wide range of neuro-degenerative impairments, in helping the following:
- Return of mental and physical faculties
- Increased strength, balance and mobility
- Relief of pain and disability
- Improved quality of life and wellbeing
These benefits observed in clients are often well beyond those achieved through existing exercise therapies.
These results have warranted a first REVIVER clinical trial for patients with Parkinson's disease and Atypical Parkinson's at Australia's Monash University and Alfred Hospital, funded by the Federal Government and CSIRO (Commonwealth Scientific and Industrial Research Organisation).
All three REVIVER devices have been listed on the Australian Register of Therapeutic Goods as a Class 1 Medical Device.
REVIVER is now demonstrating incredible results in improving balance and mobility in all types of patients with all types of neuromuscular diseases and conditions who have difficulty moving, balancing, and exercising.
It allows people to exercise far beyond their unassisted capacity, including those who are so debilitated that they were no longer able to perform exercise.
The device has been under testing and development at a pilot clinic in Sydney, Australia. Outcomes at the pilot clinic have been extremely promising, with PD users experiencing a 22% (p<1x10-5; N=15, unpublished data) increase in mobility (reduction in timed up and go times; TUG) over an average period of 26 days.
Users also report improved balance, improved muscle tone, and capacity to return to desisted activities such as walking unassisted, climbing stairs and swimming. Numerous patients had lost the ability to walk unassisted but regained this ability after 2-10 weeks of training on this machine.
Although other therapies may feature elements of the above benefits, no device to our knowledge has all the of these attributes in a single machine. Furthermore, given the tiled motion of the head in this therapy, it may also have an effect on glymphatic fluid and CSF flow in the brain.
Comments